512
Participants
Start Date
September 15, 2018
Primary Completion Date
August 30, 2021
Study Completion Date
January 18, 2022
eryaspase
L-asparaginase encapsulated in erythrocytes (red blood cells)
Gemcitabine plus Abraxane
gemcitabine, Abraxane
Irinotecan plus 5-FU plus leucovorin
irinotecan, 5-FU, leucovorin
Weill Cornell Medicine, New York
Stony Brook University, Stony Brook
Roswell Park Cancer Institute, Buffalo
University of Rochester Medical Center, Rochester
Georgetown University Hospital, Washington D.C.
Duke University, Durham
Institut de Cancerologie, Brest
Boca Raton Regional Hospital, Boca Raton
University of Minnesota Health Clinics and Surgery Center, Minneapolis
Ochsner Clinic Foundation, New Orleans
Arizona Cancer Center, Scottsdale
St. Joseph Heritage Healthcare, Fullerton
University of California Davis Medical Center, Sacramento
Medical Oncology Associates, Spokane
Beth Israel Deaconess Medical Center, Boston
Hammersmith Hospital, London
Lead Sponsor
ERYtech Pharma
INDUSTRY